REQUEST A DEMO
Total
USD $0.00
Search more companies

Solomon Drug Corporation (Philippines)

Main Activities: Pharmacies and Drug Stores
Full name: Solomon Drug Corporation Profile Updated: December 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The subject is engaged with the retail sale of pharmaceutical products, medical goods, and related health products through physical outlets. Activities include dispensing prescription medications, offering over-the-counter drugs, and providing basic health and wellness products to consumers.

Headquarters
Gatuslao-Ballesteros Streets
Bacolod; Negros Occidental; Postal Code: 6100

Contact Details: Purchase the Solomon Drug Corporation report to view the information.

Basic Information
Total Employees:
Purchase the Solomon Drug Corporation report to view the information.
Financial Auditors:
Purchase the Solomon Drug Corporation report to view the information.
Incorporation Date:
October 13, 2005
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Solomon Drug Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
14.26%
Total operating revenue
13.86%
Operating profit (EBIT)
74.33%
EBITDA
74.33%
Net Profit (Loss) for the Period
13.75%
Total Assets
9.81%
Total Equity
10.03%
Operating Profit Margin (ROS)
0.35%
Net Profit Margin
0%
Return on Equity (ROE)
0.29%
Debt/Equity
-130.9%
Quick Ratio
-0.19%
Cash Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?